tm logo
DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY
Live/Pending
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER

record initialized not assigned to examiner

on 03 Jan 2025

Last Applicant/ Owned by

69 Innovation Dr., Milton Park, Abingdon

Oxfordshire

GB

OX144RQ

Serial Number

98935691 filed on 03rd Jan 2025

Registration Number

N/A

Correspondent Address

Melanie Howard

Melanie Howard Loeb & Loeb LLP

Los Angeles, CA 90067

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY

Pharmaceutical drug research and development services; research and development of vaccines and medicines; information, advisory and consultancy services relating to the aforesaid Biological preparations in the nature of viruses for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; biological preparations in the nature of viruses for t Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical drug research and development services; research and development of vaccines and medicines; information, advisory and consultancy services relating to the aforesaid


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Biological preparations in the nature of viruses for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; biological preparations in the nature of viruses for the treatment of cancer; biological preparations in the nature of viruses for inducing immune response; pharmaceuticals, namely, pharmaceutical preparations and pharmaceutical substances for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceuticals, namely, anti-infectives for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceuticals for the treatment of cancer; pharmaceutical preparations for inducing immune response; vaccines; immunotherapy products, namely, pharmaceutical products for the prevention and treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; gene therapy products, namely, therapeutics for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98935691

Mark Type

No Service Mark

Attorney Docket Number

No 221834-00059

44D Filed

No

44D Current

No

44E filed

Yes

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
03rd Jan 2025NEW APPLICATION ENTERED